| BMS-214662 in Treating Patients With Advanced Solid Tumors (NCT00004877) | Memorial Sloan Kettering Cancer Center | 1999-07-01 |
| UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia (NCT00019838) | National Cancer Institute (NCI) | 1999-07-01 |
| Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors (NCT00019630) | National Cancer Institute (NCI) | 1999-07-01 |
| ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer (NCT00006106) | National Cancer Institute (NCI) | 1999-07-01 |
| Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics of BIBB 1464 MS in Healthy Male Subjects, Combined With Preliminary Evaluation of Relative Bioavailability and Effect of Food (NCT02229838) | Boehringer Ingelheim | 1999-07-01 |
| Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer (NCT00005630) | Memorial Sloan Kettering Cancer Center | 1999-07-01 |
| Transcranial Magnetic Stimulation in Depression (NCT00018746) | US Department of Veterans Affairs | 1999-07-01 |
| Bioavailability of BIBR 1048 MS Tablets in Healthy Subjects With or Without Food (NCT02170922) | Boehringer Ingelheim | 1999-07-01 |
| Paclitaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors (NCT00004863) | Montefiore Medical Center | 1999-07-01 |
| Stromal Therapy of Osteodysplasia After Allogeneic Bone Marrow Transplantation (NCT00186914) | St. Jude Children's Research Hospital | 1999-07-01 |
| Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors (NCT00004082) | Beth Israel Deaconess Medical Center | 1999-07-01 |
| Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases (NCT00004930) | Memorial Sloan Kettering Cancer Center | 1999-07-01 |
| Procarbazine in Treating Patients With Recurrent Brain Tumor (NCT00004004) | New Approaches to Brain Tumor Therapy Consortium | 1999-07-01 |
| Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer (NCT00004065) | Memorial Sloan Kettering Cancer Center | 1999-07-01 |
| Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer (NCT00004211) | Duke University | 1999-07-01 |
| Dose-finding Study of Novel Erythropoiesis Stimulating Protein (NESP) for the Treatment of Anaemia in Subjects With Solid Tumours Receiving Multicycle Chemotherapy (NCT00540384) | Amgen | 1999-07-01 |
| G-CSF for Granulocyte Donation (NCT00001842) | National Institutes of Health Clinical Center (CC) | 1999-07-01 |
| Interleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial Infections (NCT00001911) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-07-01 |
| Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer (NCT00019773) | National Cancer Institute (NCI) | 1999-07-01 |
| Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer (NCT00004062) | Lucille P. Markey Cancer Center at University of Kentucky | 1999-07-01 |
| Vaccine Therapy in Treating Patients With Liver Cancer (NCT00005629) | Jonsson Comprehensive Cancer Center | 1999-07-01 |
| Pharmacokinetics and Safety of Asasantin Extended Release (RAD-SP) Capsules in Japanese Healthy Male Volunteers (NCT02273479) | Boehringer Ingelheim | 1999-07-01 |
| Study to Investigate the Safety, Tolerability, Biological Effects and Preliminary Pharmacokinetics of Increasing Doses of BIIL 284 BS in Healthy Male Volunteers (NCT02273414) | Boehringer Ingelheim | 1999-07-01 |
| Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors (NCT00004059) | Memorial Sloan Kettering Cancer Center | 1999-07-01 |
| Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer (NCT00004070) | Dana-Farber Cancer Institute | 1999-07-01 |
| Single Rising Dose Tolerability Study of BIBN 4096 BS in Healthy Male and Female Volunteers (NCT02198326) | Boehringer Ingelheim | 1999-07-01 |
| Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions (NCT00652704) | Par Pharmaceutical, Inc. | 1999-07-01 |
| BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy (NCT00004927) | R-Pharm | 1999-07-01 |
| PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma (NCT00004002) | NYU Langone Health | 1999-07-01 |
| 6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia (NCT00003997) | National Cancer Institute (NCI) | 1999-07-01 |
| Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia (NCT00022880) | Corixa Corporation | 1999-07-01 |
| Relative Bioavailability of Ambroxol Hydrochloride Lozenge in Comparison to Ambroxol Hydrochloride Syrup (Mucosolvan®) in Healthy Female and Male Volunteers (NCT02194296) | Boehringer Ingelheim | 1999-06-01 |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma (NCT00005633) | Memorial Sloan Kettering Cancer Center | 1999-06-01 |
| Relative Bioavailability of Meloxicam 2 x 7.5 mg Tablets Compared to 15 mg Tablet and Dose Proportionality Over a Dose Range of 7.5 mg and 15 mg in Healthy Volunteers (NCT02276352) | Boehringer Ingelheim | 1999-06-01 |
| Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine (NCT00592748) | Massachusetts General Hospital | 1999-06-01 |
| Combination Drug Treatment of Pediatric HIV Infection (NCT00001818) | National Cancer Institute (NCI) | 1999-06-01 |
| Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical Carcinoma (NCT00184093) | University of Southern California | 1999-06-01 |
| Chemotherapy in Treating Patients Who Have Hematologic Cancer (NCT00004047) | Daiichi Sankyo | 1999-06-01 |
| Combined Behavioral and Pharmacologic Treatment of Polydrug Abuse (NCT00292123) | National Institute on Drug Abuse (NIDA) | 1999-06-01 |
| Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma (NCT00004158) | Fred Hutchinson Cancer Center | 1999-06-01 |
| A Limited Food Effect Study of Gabapentin 800 mg Tablets (NCT00865631) | Actavis Inc. | 1999-06-01 |
| Safety and Tolerability of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease (NCT01157156) | Sanofi | 1999-06-01 |
| PNU 166148 in Treating Patients With Metastatic Solid Tumors (NCT00004076) | University of Glasgow | 1999-06-01 |
| Stem Cell Transplant to Treat Patients With Systemic Sclerosis (NCT00058578) | Baylor College of Medicine | 1999-06-01 |
| Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast Cancer (NCT00724386) | University of Chicago | 1999-06-01 |
| Treating High Risk Leukemia With CD40 Ligand & IL-2 Gene Modified Tumor Vaccine (NCT00058799) | Baylor College of Medicine | 1999-06-01 |
| Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation (NCT00609739) | Masonic Cancer Center, University of Minnesota | 1999-06-01 |
| Narrowband UVB Light Therapy to Patients With Dark Skin Types Who Have 10% of Their Body Involved With Psoriasis Vulgaris. (NCT00220025) | Mary Sullivan-Whalen | 1999-06-01 |
| A Phase IB Study Of Oral SCH 66336 Preoperatively In Patients With Head And Neck Squamous Cell Cancer (NCT00038584) | M.D. Anderson Cancer Center | 1999-06-01 |
| Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NCT00019708) | National Cancer Institute (NCI) | 1999-06-01 |
| Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia (NCT00005802) | Fred Hutchinson Cancer Center | 1999-06-01 |
| A Relative Bioavailability Study of Gabapentin 800 mg Tablets Under Fasting Conditions (NCT00864760) | Actavis Inc. | 1999-06-01 |
| Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer (NCT00004187) | Swiss Cancer Institute | 1999-06-01 |
| Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer (NCT00005632) | Memorial Sloan Kettering Cancer Center | 1999-06-01 |
| Pharmacokinetic Study of Seresis® in the Skin in Healthy Young Female Volunteers (NCT02191852) | Boehringer Ingelheim | 1999-06-01 |
| SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084) (NCT00002960) | Merck Sharp & Dohme LLC | 1999-06-01 |
| Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome (NCT00003959) | Memorial Sloan Kettering Cancer Center | 1999-06-01 |
| Comparative Bioavailability Study of Lisinopril Tablets, 10 mg (NCT01375244) | Par Pharmaceutical, Inc. | 1999-06-01 |
| Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy (NCT00006220) | Washington University School of Medicine | 1999-06-01 |
| Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00010231) | University of Pittsburgh | 1999-06-01 |
| R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia (NCT00004009) | University of Maryland, Baltimore | 1999-06-01 |
| Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00005092) | M.D. Anderson Cancer Center | 1999-05-28 |
| Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Non Hodgkin's Lymphoma (NHL) Patients With Greater Than 25% Bone Marrow Involvement (NCT00992758) | GlaxoSmithKline | 1999-05-28 |
| Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer (NCT00003927) | City of Hope Medical Center | 1999-05-18 |
| Multiple Oral Doses of BIBR 1048 MS Solution in Healthy Volunteers (NCT02170831) | Boehringer Ingelheim | 1999-05-01 |
| Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma (NCT00115453) | Boneca Corporation | 1999-05-01 |
| Pharmacokinetic Interaction Between Nevirapine and Saquinavir-sgc in HIV-1 Infected Patients (NCT02184286) | Boehringer Ingelheim | 1999-05-01 |
| Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer (NCT00005993) | Masonic Cancer Center, University of Minnesota | 1999-05-01 |
| Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow Involvement (NCT00022906) | Corixa Corporation | 1999-05-01 |
| Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (Allogeneic Prostate GVAX®) (NCT00140387) | Cell Genesys | 1999-05-01 |
| O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors (NCT00003765) | National Cancer Institute (NCI) | 1999-05-01 |
| High-Dose Proton/Photon RT + Surgery of Sarcomas of the Thoracic, Lumbar Spine/Sacrum (NCT00592345) | Massachusetts General Hospital | 1999-05-01 |
| Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies (NCT00038051) | M.D. Anderson Cancer Center | 1999-05-01 |
| Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer (NCT00003799) | National Cancer Institute (NCI) | 1999-05-01 |
| Vaccine Therapy in Treating Patients With Breast Cancer (NCT00004156) | Memorial Sloan Kettering Cancer Center | 1999-05-01 |
| Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NCT00003567) | Case Comprehensive Cancer Center | 1999-05-01 |
| Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults (NCT00002427) | Research Institute for Genetic and Human Therapy | 1999-05-01 |
| Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate Cancer (NCT00140400) | Cell Genesys | 1999-05-01 |
| Immunotherapy of Melanoma Patients (NCT00112216) | Centre Hospitalier Universitaire Vaudois | 1999-05-01 |
| Vaccine Therapy With gp100 and/or Sargramostim in Treating Patients With Malignant Melanoma (NCT00003897) | University of Wisconsin, Madison | 1999-05-01 |
| CHS 828 in Treating Patients With Solid Tumors (NCT00003979) | European Organisation for Research and Treatment of Cancer - EORTC | 1999-04-01 |
| Increasing Dose Tolerance Study in Healthy Male Volunteers After Administration of BIII 890 CL (NCT02268136) | Boehringer Ingelheim | 1999-04-01 |
| Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors (NCT00004016) | University of Rochester | 1999-04-01 |
| A Multiple Increasing Dose Safety and Tolerability Study After Inhalation Administration of BIIX 1 XX in Healthy Male Volunteers (NCT02198313) | Boehringer Ingelheim | 1999-04-01 |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer (NCT00003704) | Alliance for Clinical Trials in Oncology | 1999-04-01 |
| Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors (NCT00179816) | Ann & Robert H Lurie Children's Hospital of Chicago | 1999-04-01 |
| Combination Chemotherapy in Treating Patients With Advanced Cancer (NCT00003956) | Memorial Sloan Kettering Cancer Center | 1999-04-01 |
| 5-Fluoro-2'-Deoxcyctidine and Tetrahydrouridine to Treat Patients With Advanced Cancer (NCT00359606) | City of Hope Medical Center | 1999-04-01 |
| Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors (NCT00004923) | Yale University | 1999-04-01 |
| Influence of a High Fat Breakfast in the Pharmacokinetics of UH-AC62MU in Healthy Subjects (NCT02183103) | Boehringer Ingelheim | 1999-04-01 |
| O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell Lymphoma (NCT00003613) | National Cancer Institute (NCI) | 1999-04-01 |
| Pharmacokinetics and Pharmacodynamics Study of Gemcabene in Healthy Volunteers (NCT02587364) | NeuroBo Pharmaceuticals Inc. | 1999-04-01 |
| Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive Adults (NCT02182765) | Boehringer Ingelheim | 1999-04-01 |
| SR-45023A in Treating Patients With Locally Advanced or Metastatic Solid Tumors (NCT00004049) | Genzyme, a Sanofi Company | 1999-04-01 |
| Relative Bioavailability and Tolerability of Two New Different Extended Release Capsules of BIBV 308 SE, Versus a Solution of BIBV 308 SE in Healthy Subjects (NCT02223013) | Boehringer Ingelheim | 1999-04-01 |
| Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants (NCT00001906) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-04-01 |
| Comparison of Biphasic Insulin Aspart (30, 50 and 70) and Insulin Aspart in Healthy Subjects (NCT01520831) | Novo Nordisk A/S | 1999-04-01 |
| Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma (NCT00003876) | Barrett Cancer Center | 1999-04-01 |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma (NCT00003792) | Baylor Health Care System | 1999-04-01 |
| Vaccine Therapy in Treating Patients With Stage IV Melanoma (NCT00003665) | National Cancer Institute (NCI) | 1999-04-01 |